Stonnington Group, LLC Amgen Inc Transaction History

Stonnington Group, LLC

$381 Million
Q1 2023

A detailed history of Stonnington Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Stonnington Group, LLC holds 23,153 shares of AMGN stock, worth $6.12 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

23,153

Previous 25,356 8.69%

Holding current value

$6.12 Million

Previous $6.66 Million 15.95%

% of portfolio

1.47%

Previous 1.87%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $497,415 - $606,265	-2,203 Reduced 8.69%	23,153 $5.6 Million
Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $103,292 - $131,245	451 Added 1.81%	25,356 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $864,619 - $975,133	-3,852 Reduced 13.39%	24,905 $6.18 Million
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $976,826 - $1.09 Million	4,234 Added 17.27%	28,757 $7.12 Million
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $3.51 Million - $3.88 Million	-16,005 Reduced 39.49%	24,523 $6.15 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $5.37 Million - $6.15 Million	27,019 Added 200.01%	40,528 $9.42 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $826,346 - $945,678	4,155 Added 44.42%	13,509 $3.14 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $316,070 - $370,314	-1,489 Reduced 13.73%	9,354 $1.96 Million
Q2 2021 Jul 09, 2021	SELL	$233.58 - $259.14 $532,562 - $590,839	-2,280 Reduced 17.37%	10,843 $2.65 Million
Q1 2021 May 21, 2021	BUY	$221.91 - $258.6 $2.91 Million - $3.39 Million	13,123 New	13,123 $3.29 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.

Account

Stonnington Group, LLC Amgen Inc Transaction History